BDRX Stock Summary and Trading Ideas (Biodexa Pharmaceuticals PLC - American Depositary Shares | NASDAQ:BDRX)

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Biodexa Pharmaceuticals PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol BDRX.

As of December 5, 2025, BDRX stock price declined to $5.04 with 12,482 million shares trading.

BDRX has a beta of 0.43, meaning it tends to be less sensitive to market movements. BDRX has a correlation of 0.01 to the broad based SPY ETF.

BDRX has a market cap of $3.12 million. This is considered a Sub-Micro Cap stock.

BDRX has underperformed the market in the last year with a return of -89.5%, while the SPY ETF gained +14.2%. In the last 3 month period, BDRX fell short of the market, returning -10.8%, while SPY returned +6.2%. However, in the most recent 2 weeks BDRX has outperformed the stock market by returning +15.1%, while SPY returned +4.0%.

BDRX support price is $4.63 and resistance is $5.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDRX shares will trade within this expected range on the day.